GRCE
NASDAQ · Pharmaceuticals
Grace Therapeutics Inc
$2.38
+0.16 (+7.21%)
Open$2.22
Previous Close$2.22
Day High$2.38
Day Low$2.21
52W High$5.18
52W Low$1.79
Volume—
Avg Volume239.9K
Market Cap36.83M
P/E Ratio—
EPS$-0.36
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+870.2% upside
Current
$2.38
$2.38
Target
$23.09
$23.09
$18.68
$23.09 avg
$33.94
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 19.56M | 18.44M | 15.17M |
| Net Income | 2.85M | 2.16M | 2.15M |
| Profit Margin | 14.6% | 11.7% | 14.2% |
| EBITDA | 5.50M | 5.11M | 4.77M |
| Free Cash Flow | 2.45M | 3.17M | 1.86M |
| Rev Growth | +16.3% | +19.0% | +18.1% |
| Debt/Equity | 0.50 | 0.57 | 0.59 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,114.20 | +0.64% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $240.15 | +0.45% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $121.17 | +1.31% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.09 | -2.55% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $78.15 | +1.70% | 12.5 | 33.00B |